Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Asia Pioneer Pharmaceutical Co., Ltd. (Asia Pioneer Pharmaceuticals) is a prominent Chinese pharmaceutical manufacturer and a core subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH). Established in 1926, the company specializes in the research, development, and large-scale production of anti-infective medications, with a particular focus on cephalosporins and penicillins. It operates as a major supplier of active pharmaceutical ingredients (APIs) and finished dosage forms, including aseptic powders for injection, oral capsules, and tablets. The company maintains a significant presence in the global market, providing high-quality generic medicines and specialized treatments in therapeutic areas such as pain management and dermatology. With multiple production bases across China, Asia Pioneer Pharmaceuticals is a key player in the national pharmaceutical industry and a critical component of the global antibiotic supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Asia Pioneer Pharmaceuticals.